INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
8.06
+0.42 (5.50%)
At close: May 13, 2025, 4:00 PM
8.21
+0.15 (1.86%)
Pre-market: May 14, 2025, 8:02 AM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $187.08 million as of May 14, 2025. Its market cap has decreased by -8.08% in one year.
Market Cap
187.08M
Enterprise Value
168.09M
1-Year Change
-8.08%
Ranking
Category
Stock Price
$8.06
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has increased from $77.82M to $187.08M, an increase of 140.38%. That is a compound annual growth rate of 15.01%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |